Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

skip to main content

Targeting inhaled corticosteroid non-adherence during pregnancy

Published online: October 8, 2020

Asthma is one of the most common conditions to affect pregnancy, with a prevalence of up to 13% worldwide. The use of asthma medications, such as inhaled corticosteroids (ICS), helps to control symptoms and reduces the risk of exacerbations. However, non-adherence to ICS is a significant clinical problem, with rates as high as 40% of women with asthma. ICS non-adherence has been associated with 29% of asthma exacerbations during pregnancy. Improving ICS non-adherence during pregnancy is therefore of clinical importance.

A study by Robijn et al., recently published in The Journal of Allergy and Clinical Immunology: In Practice, aimed to identify factors associated with ICS non-adherence in early-mid pregnancy as well as persistent non-adherence during pregnancy. The authors utilized data from 3 Australian clinical trials conducted between 2004 and 2019. The investigators based non-adherence on the self-reported number of dosages missed in the past week. Women in the study were classified as being persistent non-adherent if they were non-adherent at least twice during the follow-up of the study.

The authors found that current smokers were twice, and ex-smokers 1.7 times, as likely to be non-adherent in early-mid pregnancy compared to never smokers. Women identifying as non-Caucasian/non-Indigenous were twice as likely to be non-adherent compared to women identifying as Caucasian. Furthermore, having received an asthma diagnosis as an adult and reduced lung function were associated with increased odds of ICS non-adherence. Factors associated with increased odds of persistent non-adherence are younger age, increased parity and not using ICS medication at study entry at 18 week’s gestation.

The factors associated with ICS non-adherence during pregnancy identified by Robijn and colleagues may help healthcare professionals to identify women who are at risk of ICS non-adherence during pregnancy and thereby implement early interventions to address medication adherence.

The Journal of Allergy and Clinical Immunology: In Practice is an official journal of the AAAAI, focusing on practical information for the practicing clinician.

Full Article